XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery

 

 

 

 

 

 

 

The International Society for Stem Cell Application (ISSCA), and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity. ISSCA and GSCG will launch their new online regenerative medicine training course, and will also launch a new adipose stem cell isolation kit, STEMPIA, at the event.

XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery .                   XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery


MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in promoting education and setting standards in regenerative medicine, in collaboration with and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity Nov. 30 – Dec. 3, 2017, in Mexico City.

Hosted by the Institute of Higher Studies in Medicine (IESM), the annual International Congress is among the largest and most well-attended aesthetic medicine events in Ibero-America. More than 1,000 physicians from around the world are expected to attend. This year’s speaker lineup includes a renowned group of professionals in the field of regenerative medicine.

ISSCA and GSCG plan to leverage the large gathering of regenerative medicine and healthcare professionals at the International Congress to launch the newest cutting-edge online regenerative medicine training course in collaboration with Stem Cell Training, Inc.

The new virtual regenerative medicine training course is designed to instruct qualified physicians in the theoretical and practical protocols necessary to effectively and expertly administer regenerative medicine procedures to their patients. Training includes instructions for harvesting and isolating stem cells. The online training program positions physicians to provide stem cell procedures in their existing practice or open a stem cell center practice and join ISSCA’s international network of stem cell specialists.

In addition, the organizations will launch STEMPIA, a new adipose-derived stem call kit. The kit provides two specially designed tubes to isolate and concentrate adipose tissue-derived stromal vascular fraction (SVF). STEMPIA offers an easier, more effective, and shorter process for SVF isolation while maintaining high viability rates. STEMPIA uses less consumables and tools compared to manual SVF isolation processes, saving both costs and time in the SVF isolation process.

ISSCA, and GSCG will also be conducting a two-day, intensive regenerative medicine certification course for qualified physicians in Mexico City following the congress. Attendees will gain hand-on training and learn how to harvest and isolate stem cells, and expertly administer stem cell treatments to patients.. Upon completing the course, participants will receive certification and will be able to use their skills to treat patients in their practice, and for career advancement.

Fiesta Americana Reforma is the conference venue and headquarters. Visit the hotel data website page for location and additional information.

To learn more about the International Conference, visit the conference website email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.

###

XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity

Regenerative medicine symposiums 2018

The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in Istanbul, Turkey, Buenos Aires, Argentina, and Seoul, Korea in 2018. The Seoul symposium will be part of, the 6th Annual International Conference of ISSCA, “Progress and Perspectives,” which will be held in Seoul in November 2018.

 

regenerative-medicine-symposiums-2018 ISSCA

MIAMI, Nov. 9, 2017—The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in the upcoming year:

  • Istanbul, Turkey, April 2018
  • Buenos Aires, Argentina, August 2018
  • Seoul, Korea, November 2018

The symposium series will culminate in the 6th Annual International Conference of ISSCA, Progress and Perspectives, in Seoul, Korea in November 2018.

The three international symposiums are part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. Each event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.

Each ISSCA symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.

The central theme of each international symposium is as follows:

•  Istanbul: Advances in Cell Therapies
•  Buenos Aires:  Next Generation Medicine: Adult Stem Cells
•  Seoul: This seminar will be part of the 6th Annual International Conference of ISSCA, “Progress and Perspectives”

Symposium dates and details will be available shortly. To learn more about the ISSCA symposiums and 6th Annual International Conference of ISSCA, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

.###

Regenerative medicine symposiums 2018 ISSCA